Home > Financial Ratios > BLISS GVS PHARMA

BLISS GVS PHARMA
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.620.600.530.420.49

What is the latest Fixed Capital/Sales ratio of BLISS GVS PHARMA ?

The latest Fixed Capital/Sales ratio of BLISS GVS PHARMA is 0.62 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.62
Mar20240.60
Mar20230.53
Mar20220.42
Mar20210.49

How is Fixed Capital/Sales of BLISS GVS PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.62
3.33
Mar2024 0.6
13.21
Mar2023 0.53
26.19
Mar2022 0.42
-14.29
Mar2021 0.49 -

Other Financial Ratios of BLISS GVS PHARMA


Compare Fixed Capital/Sales ratio of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹1,647.3 Cr -2% 9.3% 23.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,764.0 Cr 2.8% 6.7% 2.8% Stock Analytics
DIVIS LABORATORIES ₹170,489.0 Cr 1.9% -0.5% 6.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,442.0 Cr 0.1% 3.4% 15.8% Stock Analytics
CIPLA ₹123,088.0 Cr 1.8% -3.2% 2.1% Stock Analytics
DR REDDYS LABORATORIES ₹105,162.0 Cr 2.7% 0.4% 3.4% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

-2%

9.3%

23.7%

SENSEX

0.9%

0.8%

7.1%


You may also like the below Video Courses